Back to Search Start Over

History of autoimmune disease and long-term survival of epithelial ovarian cancer: The extreme study.

Authors :
Hannibal, Charlotte Gerd
Kjaer, Susanne K.
Galanakis, Michael
Hertzum-Larsen, Rasmus
Maltesen, Thomas
Baandrup, Louise
Source :
Gynecologic Oncology. Mar2024, Vol. 182, p1-6. 6p.
Publication Year :
2024

Abstract

Patients with autoimmune disease may have impaired cancer survival. The aim was to investigate the association between autoimmune disease and ovarian cancer survival. From the Extreme study, we included women diagnosed with epithelial ovarian cancer (EOC) in Denmark during 1990–2014 (n = 11,870). Information on exposure and covariates was retrieved from nationwide registries. Using pseudo-values, we estimated absolute and relative 5- and 10-year survival probabilities with 95% confidence intervals (CIs) for autoimmune diseases combined and for the four most common individual disorders in our study population, namely type 1 diabetes, rheumatoid arthritis, Graves' disease, and inflammatory bowel disease. The overall 5- and 10-year absolute survival probabilities were 35% and 24%, respectively, in women with EOC without autoimmune disease. Autoimmune diseases combined was not significantly associated with survival among women with EOC (5-year adjusted relative survival probability = 1.01, 95% CI: 0.94–1.09; 10-year adjusted relative survival probability = 0.90, 95% CI: 0.81–1.00). However, stratification by disease stage showed an impaired 10-year survival in women with autoimmune disease and a localized EOC (relative survival probability = 0.86, 95% CI: 0.76–0.97). None of the individual autoimmune diseases were statistically significantly associated with EOC survival. Only among women with localized EOC, there seemed to be a long-term survival loss associated with a history of autoimmune disease. In contrast, no significant association between a history of autoimmune disease and survival was observed in women with nonlocalized EOC where the survival is already low. [Display omitted] • Long-term survival of localized ovarian cancer seemed impaired in women with a history of autoimmune disease. • No significant association was observed between prior autoimmune disease and long-term nonlocalized ovarian cancer survival. • The most common autoimmune diseases, including type 1 diabetes, were not associated with long-term ovarian cancer survival. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00908258
Volume :
182
Database :
Academic Search Index
Journal :
Gynecologic Oncology
Publication Type :
Academic Journal
Accession number :
176195889
Full Text :
https://doi.org/10.1016/j.ygyno.2023.12.024